Pfizer an outperformer: Prabhudas Lilladher

Published on Thu, Jul 03, 2008 at 12:10 |  Source : Moneycontrol.com

Updated at Thu, Jul 03, 2008 at 12:16  

6565 Investors following Pfizer. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

Prabhudas Lilladher has maintained its outperformer rating on Pfizer with a target price of Rs 732 in its July 1, 2008 research report. "We expect the company to report 7% CAGR net sales and 14% CAGR net profit over FY07-09. We also expect its EBIDTA margin to improve from 22.5% in FY07 to 24.7% in FY09 due to the restructuring."

"At the CMP of Rs 551, the stock trades at 11.3x FY08E EPS of Rs 48.9 and 9.8x FY09E EPS of Rs 56.3. We maintain Outperformer rating on the scrip with a price target of Rs 732 (13x FY09 earnings) over the next 12 months, an upside of 33.0% over the CMP," says Lilladher's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment.......

Attachments : Pfizer-1-7-08-PL.pdf

  

More on Moneycontrol

Trending News

Business News

Next-gen Macbooks may come with Retina display
Will RBI regulation prevent a gold loan bubble? "Will RBI regulation prevent a gold loan bubble?"

Sun Pharma Says Robust OPM Fuelled By Strong Taro Performance, Weaker Rupee

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 13 2012, 17:40

Bullish on gold, but see price correction ahead: Ventura

- in Commodities

Interviews

Feb 13 2012, 19:27 | Source: CNBC-TV18

'Diverse offerings in power helping to withstand headwinds'  

Feb 13 2012, 18:28 | Source: CNBC-TV18

SBI: Expect NPAs to improve; restructuring not red flag  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com